Jane Street’s Processa Pharmaceuticals PCSA Stock Holding History

Jane Street’s Portfolio PCSA Stock Details PCSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.5K	Buy	+13,264	New	+$34.3K	﹤0.01%	11146
2026 Q1	–	Sell	-30,190	Closed	-$86.9K	–	12633
2025 Q4	$86.9K	Buy	+30,190	New	+$211K	﹤0.01%	10251
2025 Q3	–	Sell	-771	Closed	-$3.95K	–	11521
2025 Q2	$3.95K	Buy	+771	New	+$5.14K	﹤0.01%	9448
2023 Q2	–	Sell	-20	Closed	-$5.02K	–	9340
2023 Q1	$5.02K	Buy	+20	New	+$8.06K	﹤0.01%	8810

Other funds holding PCSA

CCM

Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return

Jane Street's PCSA Position: Q2 2026 in Review

Jane Street opened a new position in Processa Pharmaceuticals (PCSA) in Q2 2026: 13,264 shares worth $25.5K. The stake represents ﹤0.01% of the portfolio and ranks #11146 among its holdings. This is a return to the name: Jane Street previously reported a position in PCSA as recently as Q4 2025.

Jane Street first reported a position in PCSA in Q1 2023 and has held it in 4 quarters since. The position peaked at $86.9K in Q4 2025. 11 funds tracked by Wall St. Rank hold PCSA as of Q2 2026.

Jane Street held 13,264 shares of Processa Pharmaceuticals worth $25.5K as of Q2 2026.
Processa Pharmaceuticals was a new Jane Street position in Q2 2026.
Processa Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #11146 holding.
Jane Street first reported a position in Processa Pharmaceuticals in Q1 2023 and has held it in 4 quarters since.
Jane Street's Processa Pharmaceuticals position peaked at $86.9K in Q4 2025.
11 funds tracked by Wall St. Rank held Processa Pharmaceuticals as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.